Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome DOI: 10.1016/j.esmoop.2020.100005
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital DOI: 10.1200/CCI.21.00177
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves DOI: 10.3390/cancers14163931
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials. DOI: 10.1177/03008916241248007
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors DOI: 10.1186/s12885-024-13073-0
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital DOI: 10.1200/CCI.21.00177
Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs DOI: 10.1016/j.ijmedinf.2025.105958
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials DOI: 10.1200/CCI.22.00137
